AlphaYouAL
Congress trade
Rep. Alan Lowenthal (D-CA) sold $506-$506 of BioMarin Pharmaceutical Inc. (BMRN) stock
Alan Lowenthal, U.S. Representative (D-CA), disclosed a sale of BioMarin Pharmaceutical Inc. (BMRN) stock worth $506-$506 in a STOCK Act filing on Sep 1, 2019.
The trade happened on Aug 15, 2019, 17 days before it was made public.
BMRN has moved -18.5% since the trade date, from $71.73 to $58.44 (Oct 1, 2026 close).
- Traded
- Aug 15, 2019
- Disclosed
- Sep 1, 2019
- Filing delay
- 17 days
- Price since
- -18.5%
- Source
- STOCK Act disclosure
Other trades in this disclosure (12)
- SellELAN$1K-$15KSep 1, 2019
- SellBRK.B$998-$998Sep 1, 2019
- SellADSK$726-$726Sep 1, 2019
- SellARCC$539-$539Sep 1, 2019
- SellVST$429-$429Sep 1, 2019
- SellVST$248-$248Sep 1, 2019
- SellBMRN$217-$217Sep 1, 2019
- BuyVSLR$97-$97Sep 1, 2019
- BuyVSLR$67-$67Sep 1, 2019
- BuyVSLR$60-$60Sep 1, 2019
- BuyVSLR$52-$52Sep 1, 2019
- BuyVSLR$22-$22Sep 1, 2019
More BMRN insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.